Motif ID: Pou6f2_Pou4f2
Z-value: 0.834


Transcription factors associated with Pou6f2_Pou4f2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Pou4f2 | ENSMUSG00000031688.3 | Pou4f2 |
Pou6f2 | ENSMUSG00000009734.11 | Pou6f2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou6f2 | mm10_v2_chr13_-_18382041_18382041 | -0.49 | 1.8e-02 | Click! |
Pou4f2 | mm10_v2_chr8_-_78436640_78436649 | -0.21 | 3.3e-01 | Click! |
Top targets:
Showing 1 to 20 of 117 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 40 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 16.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.4 | 7.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.9 | 6.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 4.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 3.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 3.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 2.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 2.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 1.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 1.4 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 1.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.2 | GO:0031424 | keratinization(GO:0031424) establishment of skin barrier(GO:0061436) |
0.1 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 0.9 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.9 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
Gene overrepresentation in cellular_component category:
Showing 1 to 16 of 16 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 16.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 3.7 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 2.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.0 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 22 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 17.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 14.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 7.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 3.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.5 | 1.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |